People with a rare and aggressive blood cancer will benefit from a potentially life saving treatment, following NICE’s recommendation of a CAR-T (chimeric antigen receptor T-cell) treatment developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback